NYMOX PHARMACEUTICAL CORP Quarterly Assets in USD from Q4 2015 to Q3 2023

Taxonomy & unit
ifrs-full: USD
Summary
Nymox Pharmaceutical Corp quarterly Assets history and growth rate from Q4 2015 to Q3 2023.
  • Nymox Pharmaceutical Corp Assets for the quarter ending September 30, 2023 was $669K, a 78.7% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $669K -$2.47M -78.7% Sep 30, 2023 6-K 2023-11-15
Q2 2023 $271K -$4.2M -93.9% Jun 30, 2023 6-K 2023-08-14
Q1 2023 $575K -$663K -53.6% Mar 31, 2023 6-K 2023-05-12
Q4 2022 $1.63M +$182K +12.6% Dec 31, 2022 6-K 2023-11-15
Q3 2022 $3.14M -$710K -18.4% Sep 30, 2022 6-K/A 2022-11-16
Q2 2022 $4.47M -$2.2M -32.9% Jun 30, 2022 6-K 2022-08-15
Q1 2022 $1.24M -$217K -14.9% Mar 31, 2022 6-K 2022-05-13
Q4 2021 $1.44M -$2.9M -66.8% Dec 31, 2021 20-F 2023-05-02
Q3 2021 $3.85M -$1.89M -32.9% Sep 30, 2021 6-K 2021-11-12
Q2 2021 $6.67M +$5.62M +532% Jun 30, 2021 6-K 2021-08-13
Q1 2021 $1.46M -$1.92M -56.8% Mar 31, 2021 6-K 2021-05-14
Q4 2020 $4.34M -$1.15M -20.9% Dec 31, 2020 20-F 2022-03-30
Q3 2020 $5.74M -$1.72M -23.1% Sep 30, 2020 6-K 2020-11-13
Q2 2020 $1.06M -$8.46M -88.9% Jun 30, 2020 6-K 2020-08-14
Q1 2020 $3.37M -$8.43M -71.4% Mar 31, 2020 6-K 2020-05-14
Q4 2019 $5.49M -$2.59M -32% Dec 31, 2019 20-F 2022-03-30
Q3 2019 $7.46M +$2.68M +56.1% Sep 30, 2019 6-K 2019-11-13
Q2 2019 $9.52M +$4.35M +84.2% Jun 30, 2019 6-K 2019-08-14
Q1 2019 $11.8M +$10.8M +1137% Mar 31, 2019 6-K 2019-05-15
Q4 2018 $8.08M +$7.1M +725% Dec 31, 2018 20-F 2021-03-29
Q3 2018 $4.78M Sep 30, 2018 6-K 2018-11-13
Q2 2018 $5.17M Jun 30, 2018 6-K 2018-08-13
Q1 2018 $954K Mar 31, 2018 6-K 2018-05-15
Q4 2017 $979K -$1.08M -52.4% Dec 31, 2017 20-F 2020-03-30
Q4 2016 $2.06M +$1.35M +189% Dec 31, 2016 20-F 2019-03-29
Q4 2015 $712K Dec 31, 2015 20-F 2018-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.